000			01509 a2200421 4500
005			20250512213642.0
264		0	_c19840907
008			198409s 0 0 eng d
022			_a0002-9343
024	7		_a10.1016/0002-9343(84)90702-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aMagorien, R D
245	0	0	_aHydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses. _h[electronic resource]
260			_bThe American journal of medicine _cAug 1984
300			_a267-74 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aCardiac Output _xdrug effects
650	0	4	_aChronic Disease
650	0	4	_aClinical Trials as Topic
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHeart Failure _xdrug therapy
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHumans
650	0	4	_aHydralazine _xadministration & dosage
650	0	4	_aKidney _xblood supply
650	0	4	_aLiver _xblood supply
650	0	4	_aLong-Term Care
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMuscles _xblood supply
650	0	4	_aRandom Allocation
700	1		_aUnverferth, D V
700	1		_aLeier, C V
773	0		_tThe American journal of medicine _gvol. 77 _gno. 2 _gp. 267-74
856	4	0	_uhttps://doi.org/10.1016/0002-9343(84)90702-2 _zAvailable from publisher's website
999			_c6431697 _d6431697